1. Home
  2. HIPO vs OCS Comparison

HIPO vs OCS Comparison

Compare HIPO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hippo Holdings Inc.

HIPO

Hippo Holdings Inc.

HOLD

Current Price

$36.90

Market Cap

907.5M

Sector

Finance

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$7.48

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIPO
OCS
Founded
2015
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
907.5M
732.4M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
HIPO
OCS
Price
$36.90
$7.48
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
★ $40.88
$36.73
AVG Volume (30 Days)
161.2K
★ 291.2K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 235.37
N/A
EPS
★ 0.65
N/A
Revenue
★ $468,600,000.00
N/A
Revenue This Year
$24.25
N/A
Revenue Next Year
$34.47
$365.20
P/E Ratio
$54.66
★ N/A
Revenue Growth
★ 25.93
N/A
52 Week Low
$24.08
$7.11
52 Week High
$38.73
$34.48

Technical Indicators

Market Signals
Indicator
HIPO
OCS
Relative Strength Index (RSI) 72.52 24.99
Support Level $24.68 N/A
Resistance Level N/A $13.49
Average True Range (ATR) 0.88 0.44
MACD 0.37 -0.04
Stochastic Oscillator 93.51 10.97

Price Performance

Historical Comparison
HIPO
OCS

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: